%PDF-1.6
%
1 0 obj
<>stream
doi:10.1371/journal.pntd.0009276
Lisa Sanderson, Marcelo da Silva, Gayathri N. Sekhar, Rachel C. Brown, Hollie Burrell-Saward, Mehmet Fidanboylu, Bo Liu, Lea Ann Dailey, Cécile A. Dreiss, Chris Lorenz, Mark Christie, Shanta J. Persaud, Vanessa Yardley, Simon L. Croft, Margarita Valero, Sarah A. Thomas
Drug reformulation for a neglected disease. The NANOHAT project to develop a safer more effective sleeping sickness drug
10.1371/journal.pntd.0009276
http://dx.doi.org/10.1371/journal.pntd.0009276
2021-04-15
false
10.1371/journal.pntd.0009276
www.plosntds.org
10.1371/journal.pntd.0009276
2021-04-15
false
www.plosntds.org
endstream
endobj
2 0 obj
<>
endobj
5 0 obj
<>/ProcSet 15 0 R/XObject<>>>
endobj
6 0 obj
[18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R]
endobj
18 0 obj
<>/Border[0 0 0]>>
endobj
19 0 obj
<>/Border[0 0 0]>>
endobj
20 0 obj
<>/Border[0 0 0]>>
endobj
21 0 obj
<>/Border[0 0 0]>>
endobj
22 0 obj
<>/Border[0 0 0]>>
endobj
23 0 obj
<>/Border[0 0 0]>>
endobj
24 0 obj
<>/Border[0 0 0]>>
endobj
25 0 obj
<>/Border[0 0 0]>>
endobj
26 0 obj
<>/Border[0 0 0]>>
endobj
34 0 obj
<>
endobj
27 0 obj
<>/Border[0 0 0]>>
endobj
35 0 obj
<>
endobj
28 0 obj
<>/Border[0 0 0]>>
endobj
36 0 obj
<>
endobj
29 0 obj
<>/Border[0 0 0]>>
endobj
37 0 obj
<>
endobj
30 0 obj
<>/Border[0 0 0]>>
endobj
38 0 obj
<>
endobj
31 0 obj
<>/Border[0 0 0]>>
endobj
39 0 obj
<>
endobj
32 0 obj
<>/Border[0 0 0]>>
endobj
40 0 obj
<>
endobj
33 0 obj
<>/Border[0 0 0]>>
endobj
41 0 obj
<>
endobj
3 0 obj
<>stream
q
Q
q
12.0189 54.5953 583.087 707.414 re
W* n
q
1 0 0 1 12.0189 54.5953 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
0.955 g
0.0001 w
200 550.615 m
576 550.615 l
576 324.615 l
200 324.615 l
f*
0.45 0.36 0.35 0.01 k
576 575.614 m
200 575.614 l
200 576.115 l
576 576.115 l
f*
0.83 0.64 0.02 0 k
270.198 224.901 m
274.961 224.901 l
h
f*
279.439 224.901 m
284.202 224.901 l
h
f*
545.896 224.901 m
550.658 224.901 l
h
f*
269.972 159.931 m
274.677 159.931 l
h
f*
279.893 159.931 m
284.655 159.931 l
h
f*
474.236 133.909 m
478.998 133.909 l
h
f*
412.498 120.926 m
417.26 120.926 l
h
f*
237.317 94.9039 m
242.079 94.9039 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.012 707.754 cm
BT
/F0 1 Tf
-0.0042 Tc
1 TL
0 0 Td
(in)Tj
0.9846 0 Td
(insulin)Tj
3.0077 0 Td
(secretion)Tj
4.2251 0 Td
(in)Tj
0.9847 0 Td
(MIN6)Tj
/F6 1 Tf
2.5959 0 Td
()Tj
/F0 1 Tf
(-cells)Tj
3.0912 0 Td
(by)Tj
1.2652 0 Td
(pentamidine)Tj
5.5977 0 Td
(may)Tj
2.0946 0 Td
(be)Tj
1.3189 0 Td
(secondary)Tj
4.78 0 Td
(to)Tj
1.0504 0 Td
(pentamidine-medi-)Tj
-30.996 -1.474 Td
(ated)Tj
2.1423 0 Td
(activation)Tj
4.3922 0 Td
(of)Tj
/F6 1 Tf
1.0444 0 Td
()Tj
/F0 1 Tf
(-cell)Tj
2.5959 0 Td
(imidazoline)Tj
5.1501 0 Td
(receptors)Tj
4.3444 0 Td
(and)Tj
1.8679 0 Td
(impairment)Tj
5.1143 0 Td
(of)Tj
1.0443 0 Td
(cell)Tj
1.6949 0 Td
(viability.)Tj
3.7238 0 Td
(Pluronic)Tj
3.7894 0 Td
(F68)Tj
-36.9039 -1.474 Td
(\(0.01%w/v\)-penta)Tj
7.7579 0 Td
(midine)Tj
3.1271 0 Td
(formulation)Tj
5.1083 0 Td
(had)Tj
1.8619 0 Td
(a)Tj
0.7698 0 Td
(similar)Tj
3.0674 0 Td
(inhibitory)Tj
4.1654 0 Td
(effect)Tj
2.6496 0 Td
(on)Tj
1.3129 0 Td
(insulin)Tj
3.0077 0 Td
(secretion)Tj
4.2311 0 Td
(as)Tj
-37.0591 -1.474 Td
(pentamidine)Tj
5.5976 0 Td
(alone)Tj
2.6317 0 Td
(and)Tj
1.862 0 Td
(an)Tj
1.3188 0 Td
(additive)Tj
3.6164 0 Td
(trypanocidal)Tj
5.544 0 Td
(effect)Tj
/F8 1 Tf
2.6496 0 Td
(in)Tj
0.9787 0 Td
(vitro)Tj
/F0 1 Tf
(.)Tj
2.3692 0 Td
(However,)Tj
4.3981 0 Td
(all)Tj
1.1995 0 Td
(Pluronics)Tj
4.2848 0 Td
(tested)Tj
-36.4504 -1.474 Td
(\(P85,)Tj
2.5839 0 Td
(P105)Tj
2.5303 0 Td
(and)Tj
1.8679 0 Td
(F68\))Tj
2.2558 0 Td
(did)Tj
1.5337 0 Td
(not)Tj
1.5993 0 Td
(significantly)Tj
5.3172 0 Td
(enhance)Tj
4.0102 0 Td
(brain)Tj
2.411 0 Td
(exposure)Tj
4.2848 0 Td
(of)Tj
1.0443 0 Td
(pentamidine.)Tj
ET
Q
q
1 j
1 J
0.0001 w
11.4998 0 0 11.4998 200.012 620.107 cm
BT
/F2 1 Tf
-0.0035 Tc
1 TL
0 0 Td
(Significance)Tj
ET
Q
q
1 j
1 J
0.0001 w
9.5 0 0 9.5 200.012 603.099 cm
BT
/F0 1 Tf
-0.0042 Tc
1 TL
0 0 Td
(These)Tj
2.9718 0 Td
(results)Tj
3.1331 0 Td
(are)Tj
1.647 0 Td
(relevant)Tj
3.7358 0 Td
(to)Tj
1.0443 0 Td
(further)Tj
3.0793 0 Td
(developing)Tj
4.989 0 Td
(block-copolymers)Tj
7.9131 0 Td
(as)Tj
1.2651 0 Td
(nanocarriers,)Tj
5.9856 0 Td
(improv-)Tj
-35.7641 -1.474 Td
(ing)Tj
1.5336 0 Td
(BBB)Tj
2.2081 0 Td
(drug)Tj
2.1961 0 Td
(penetration)Tj
5.162 0 Td
(and)Tj
1.8619 0 Td
(understanding)Tj
6.4809 0 Td
(the)Tj
1.5933 0 Td
(side)Tj
2.029 0 Td
(effects)Tj
3.145 0 Td
(of)Tj
1.0443 0 Td
(pentamidine.)Tj
ET
Q
q
1 j
1 J
0.0001 w
11.9999 0 0 11.9999 209.99 532.63 cm
BT
/F0 1 Tf
-0.0033 Tc
1 TL
0 0 Td
(Author)Tj
3.137 0 Td
(summary)Tj
ET
Q
q
1 j
1 J
0.0001 w
10 0 0 10 209.99 514.601 cm
BT
/F9 1 Tf
-0.004 Tc
1 TL
0 0 Td
(Sleeping)Tj
3.5829 0 Td
(sickness)Tj
3.4583 0 Td
(or)Tj
1.0941 0 Td
(human)Tj
3.0728 0 Td
(African)Tj
3.2371 0 Td
(Trypanosomiasis)Tj
7.0356 0 Td
(\(HAT\))Tj
2.9593 0 Td
(is)Tj
0.8447 0 Td
(a)Tj
0.652 0 Td
(disease)Tj
3.0104 0 Td
(caused)Tj
2.914 0 Td
(by)Tj
1.1792 0 Td
(a)Tj
0.6519 0 Td
(para-)Tj
-33.6923 -1.2982 Td
(site,)Tj
1.7971 0 Td
(which)Tj
2.6475 0 Td
(is)Tj
0.8504 0 Td
(transferred)Tj
4.6375 0 Td
(to)Tj
1.0261 0 Td
(humans)Tj
3.4356 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4683 0 Td
(bite)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(infected)Tj
3.4185 0 Td
(tsetse)Tj
2.3868 0 Td
(fly.)Tj
1.4343 0 Td
(There)Tj
2.5795 0 Td
(are)Tj
1.4457 0 Td
(two)Tj
1.7121 0 Td
(dis-)Tj
-33.9588 -1.2983 Td
(ease)Tj
1.8651 0 Td
(stages:)Tj
2.7836 0 Td
(the)Tj
1.474 0 Td
(first)Tj
1.8029 0 Td
(stage)Tj
2.2053 0 Td
(is)Tj
0.8447 0 Td
(the)Tj
1.4684 0 Td
(blood-based)Tj
5.1193 0 Td
(stage)Tj
2.2053 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(disease)Tj
3.016 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4684 0 Td
(second)Tj
3.016 0 Td
(stage)Tj
-31.4813 -1.3039 Td
(affects)Tj
2.7382 0 Td
(the)Tj
1.4683 0 Td
(brain.)Tj
2.5739 0 Td
(It)Tj
0.856 0 Td
(is)Tj
0.8504 0 Td
(fatal)Tj
1.9219 0 Td
(if)Tj
0.771 0 Td
(left)Tj
1.4797 0 Td
(untreated.)Tj
4.2973 0 Td
(The)Tj
1.7801 0 Td
(blood-brain)Tj
4.9947 0 Td
(barrier)Tj
2.965 0 Td
(\(BBB\))Tj
2.6418 0 Td
(makes)Tj
2.7553 0 Td
(the)Tj
1.4683 0 Td
(brain)Tj
-33.5619 -1.2983 Td
(stage)Tj
2.2053 0 Td
(difficult)Tj
3.3505 0 Td
(to)Tj
1.0262 0 Td
(treat)Tj
2.0466 0 Td
(because)Tj
3.3165 0 Td
(it)Tj
0.788 0 Td
(prevents)Tj
3.617 0 Td
(99%)Tj
1.9275 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1509 0 Td
(drugs)Tj
2.4718 0 Td
(from)Tj
2.2053 0 Td
(entering)Tj
3.566 0 Td
(the)Tj
1.4683 0 Td
(brain)Tj
2.3471 0 Td
(from)Tj
-32.5018 -1.2982 Td
(the)Tj
1.4683 0 Td
(blood.)Tj
2.7439 0 Td
(Those)Tj
2.6475 0 Td
(anti-HAT)Tj
4.184 0 Td
(drugs)Tj
2.4718 0 Td
(that)Tj
1.7801 0 Td
(do)Tj
1.2529 0 Td
(enter)Tj
2.2847 0 Td
(the)Tj
1.4684 0 Td
(brain)Tj
2.347 0 Td
(are)Tj
1.4514 0 Td
(toxic)Tj
2.1826 0 Td
(and)Tj
1.7291 0 Td
(have)Tj
2.058 0 Td
(serious)Tj
3.0387 0 Td
(side)Tj
-33.1084 -1.3039 Td
(effects.)Tj
2.9536 0 Td
(Pentamidine)Tj
5.3348 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(less)Tj
1.61 0 Td
(toxic)Tj
2.1827 0 Td
(blood)Tj
2.5171 0 Td
(stage)Tj
2.1997 0 Td
(drug,)Tj
2.3357 0 Td
(which)Tj
2.6533 0 Td
(our)Tj
1.627 0 Td
(research)Tj
3.5547 0 Td
(has)Tj
1.542 0 Td
(shown)Tj
2.846 0 Td
(has)Tj
1.542 0 Td
(a)Tj
-34.401 -1.2983 Td
(limited)Tj
3.0727 0 Td
(ability)Tj
2.6929 0 Td
(to)Tj
1.0261 0 Td
(cross)Tj
2.2394 0 Td
(the)Tj
1.474 0 Td
(BBB)Tj
1.9559 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0261 0 Td
(its)Tj
1.1452 0 Td
(removal)Tj
3.4752 0 Td
(by)Tj
1.1849 0 Td
(proteins)Tj
3.5149 0 Td
(called)Tj
2.5172 0 Td
(transporters.)Tj
5.3121 0 Td
(The)Tj
-32.3374 -1.2983 Td
(objective)Tj
3.7813 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6725 0 Td
(study)Tj
2.3924 0 Td
(was)Tj
1.7008 0 Td
(to)Tj
1.0204 0 Td
(use)Tj
1.5364 0 Td
(Pluronic)Tj
3.668 0 Td
(to)Tj
1.0262 0 Td
(improve)Tj
3.5829 0 Td
(pentamidine)Tj
5.2951 0 Td
(delivery)Tj
3.3846 0 Td
(to)Tj
1.0261 0 Td
(target)Tj
2.5115 0 Td
(sites,)Tj
-33.613 -1.3039 Td
(whilst)Tj
2.6078 0 Td
(reducing)Tj
3.7701 0 Td
(its)Tj
1.1508 0 Td
(side)Tj
1.7972 0 Td
(effects.)Tj
2.9537 0 Td
(Pluronic)Tj
3.668 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.6519 0 Td
(polymer,)Tj
3.7871 0 Td
(which)Tj
2.6475 0 Td
(can)Tj
1.6271 0 Td
(assemble)Tj
3.7927 0 Td
(into)Tj
1.8425 0 Td
(micelles)Tj
-31.1468 -1.2983 Td
(and)Tj
1.7291 0 Td
(encapsulate)Tj
4.8585 0 Td
(the)Tj
1.4684 0 Td
(drug.)Tj
2.3414 0 Td
(Thus,)Tj
2.4718 0 Td
(prolonging)Tj
4.6658 0 Td
(its)Tj
1.1451 0 Td
(circulation)Tj
4.5355 0 Td
(time)Tj
2.0239 0 Td
(and)Tj
1.7348 0 Td
(protecting)Tj
4.3369 0 Td
(it.)Tj
1.0092 0 Td
(Our)Tj
-32.3204 -1.2982 Td
(study)Tj
2.3924 0 Td
(indicated)Tj
3.9344 0 Td
(that)Tj
1.7802 0 Td
(the)Tj
1.4683 0 Td
(selected)Tj
3.3506 0 Td
(Pluronics)Tj
4.0308 0 Td
(did)Tj
1.542 0 Td
(not)Tj
1.5704 0 Td
(increase)Tj
3.4753 0 Td
(the)Tj
1.4683 0 Td
(brain)Tj
2.3471 0 Td
(delivery)Tj
3.3902 0 Td
(of)Tj
1.0148 0 Td
(pentami-)Tj
-31.7648 -1.2983 Td
(dine.)Tj
2.211 0 Td
(However.)Tj
4.0818 0 Td
(Pluronic-pentamidine)Tj
9.0935 0 Td
(formulations)Tj
5.3971 0 Td
(were)Tj
2.1203 0 Td
(identified)Tj
4.0592 0 Td
(that)Tj
1.7802 0 Td
(harboured)Tj
4.4163 0 Td
(trypa-)Tj
-33.1594 -1.3039 Td
(nocidal)Tj
3.1747 0 Td
(activity)Tj
3.1181 0 Td
(and)Tj
1.7291 0 Td
(did)Tj
1.5421 0 Td
(not)Tj
1.576 0 Td
(increase)Tj
3.4696 0 Td
(safety)Tj
2.4832 0 Td
(concerns)Tj
3.8267 0 Td
(compared)Tj
4.2406 0 Td
(to)Tj
1.0261 0 Td
(unformulated)Tj
-26.1862 -1.2983 Td
(pentamidine.)Tj
ET
Q
q
1 j
1 J
0.0001 w
11.9999 0 0 11.9999 200.012 294.973 cm
BT
/F2 1 Tf
-0.0033 Tc
1 TL
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0.0001 w
10 0 0 10 200.012 278.022 cm
BT
/F9 1 Tf
-0.004 Tc
1 TL
0 0 Td
(Human)Tj
3.3165 0 Td
(African)Tj
3.2371 0 Td
(trypanosomiasis)Tj
6.7294 0 Td
(\(HAT)Tj
2.6192 0 Td
(or)Tj
1.0998 0 Td
(sleeping)Tj
3.4753 0 Td
(sickness\))Tj
3.7984 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(potentially)Tj
4.4617 0 Td
(fatal)Tj
1.9218 0 Td
(disease)Tj
-32.1616 -1.3039 Td
(caused)Tj
2.9139 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4684 0 Td
(parasite)Tj
/F13 1 Tf
3.3278 0 Td
( )Tj
5.6466 0 Td
(\n\r)Tj
2.6362 0 Td
()Tj
/F9 1 Tf
(.)Tj
2.0749 0 Td
(Recent)Tj
2.9594 0 Td
(epidemiological)Tj
6.565 0 Td
(studies)Tj
2.982 0 Td
(in)Tj
1.0375 0 Td
(30)Tj
1.1735 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(36)Tj
-36.4533 -1.2982 Td
(African)Tj
3.2371 0 Td
(countries)Tj
3.9458 0 Td
(listed)Tj
2.3414 0 Td
(as)Tj
1.0205 0 Td
(endemic)Tj
3.651 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(disease)Tj
3.016 0 Td
(indicate)Tj
3.4072 0 Td
(that,)Tj
2.007 0 Td
(whilst)Tj
2.6021 0 Td
(the)Tj
1.474 0 Td
(number)Tj
3.4129 0 Td
(of)Tj
1.0148 0 Td
(disease)Tj
-33.9871 -1.2983 Td
(cases)Tj
2.2223 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(decreasing)Tj
4.4674 0 Td
(since)Tj
2.245 0 Td
(1990,)Tj
2.3471 0 Td
(there)Tj
2.262 0 Td
(are)Tj
1.4514 0 Td
(still)Tj
1.6384 0 Td
(~4,000)Tj
2.9253 0 Td
(new)Tj
1.8765 0 Td
(infections/year,)Tj
6.395 0 Td
(and)Tj
1.7291 0 Td
(~15,000)Tj
-33.2218 -1.3039 Td
(cases)Tj
2.2223 0 Td
(worldwide)Tj
4.456 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2643 0 Td
(2)Tj
0 g
(].)Tj
1.2586 0 Td
(Furthermore,)Tj
5.6182 0 Td
(there)Tj
2.262 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(substantial)Tj
4.5014 0 Td
(unreported)Tj
4.7395 0 Td
(burden)Tj
3.1237 0 Td
(of)Tj
1.0148 0 Td
(HAT)Tj
2.2847 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
-33.0517 -1.2983 Td
(The)Tj
1.7858 0 Td
(disease)Tj
3.016 0 Td
(has)Tj
1.5421 0 Td
(two)Tj
1.7121 0 Td
(stagesa)Tj
3.5149 0 Td
(haemolymphatic)Tj
6.9165 0 Td
(stage)Tj
2.2053 0 Td
(after)Tj
2.0353 0 Td
(the)Tj
1.4683 0 Td
(bite)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(infected)Tj
3.4186 0 Td
(tsetse)Tj
2.3867 0 Td
(fly,)Tj
-35.1323 -1.2982 Td
(followed)Tj
3.651 0 Td
(by)Tj
1.1792 0 Td
(a)Tj
0.6519 0 Td
(central)Tj
2.965 0 Td
(nervous)Tj
3.4186 0 Td
(system)Tj
2.9367 0 Td
(\(CNS\))Tj
2.7722 0 Td
(stage)Tj
2.2054 0 Td
(when)Tj
2.4037 0 Td
(the)Tj
1.4684 0 Td
(parasite)Tj
3.3278 0 Td
(penetrates)Tj
4.32 0 Td
(the)Tj
1.4683 0 Td
(brain,)Tj
2.5739 0 Td
(caus-)Tj
-35.3421 -1.304 Td
(ing)Tj
1.5023 0 Td
(death)Tj
2.4264 0 Td
(if)Tj
0.7767 0 Td
(left)Tj
1.474 0 Td
(untreated.)Tj
4.303 0 Td
(The)Tj
1.7801 0 Td
(blood-brain)Tj
4.9947 0 Td
(barrier)Tj
2.965 0 Td
(\(BBB\))Tj
2.6362 0 Td
(makes)Tj
2.7552 0 Td
(the)Tj
1.4741 0 Td
(CNS)Tj
2.0919 0 Td
(stage)Tj
2.2053 0 Td
(difficult)Tj
3.3506 0 Td
(to)Tj
1.0261 0 Td
(treat)Tj
-35.7616 -1.2982 Td
(because)Tj
3.3165 0 Td
(it)Tj
0.788 0 Td
(prevents)Tj
3.617 0 Td
(99%)Tj
1.9275 0 Td
(of)Tj
1.0148 0 Td
(all)Tj
1.1509 0 Td
(known)Tj
3.0047 0 Td
(compounds)Tj
4.9549 0 Td
(from)Tj
2.2054 0 Td
(entering)Tj
3.5659 0 Td
(the)Tj
1.474 0 Td
(brain,)Tj
2.5739 0 Td
(including)Tj
4.0421 0 Td
(most)Tj
-33.6356 -1.2983 Td
(anti-HAT)Tj
4.1782 0 Td
(drugs)Tj
2.4775 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
2.5908 0 Td
(Those)Tj
2.6532 0 Td
(that)Tj
1.7745 0 Td
(do)Tj
1.2586 0 Td
(enter)Tj
2.2847 0 Td
(the)Tj
1.4683 0 Td
(brain)Tj
2.3471 0 Td
(are)Tj
1.4513 0 Td
(toxic)Tj
2.177 0 Td
(compounds,)Tj
5.1874 0 Td
(can)Tj
1.6271 0 Td
(have)Tj
2.0579 0 Td
(serious)Tj
-33.5336 -1.2983 Td
(side)Tj
1.7971 0 Td
(effects,)Tj
2.9537 0 Td
(are)Tj
1.4456 0 Td
(complex)Tj
3.6227 0 Td
(to)Tj
1.0261 0 Td
(administer)Tj
4.5411 0 Td
(and/or)Tj
2.9367 0 Td
(are)Tj
1.4456 0 Td
(expensive.)Tj
4.3314 0 Td
(Pentamidine)Tj
5.3347 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(less)Tj
1.6157 0 Td
(toxic)Tj
2.177 0 Td
(blood)Tj
-34.7298 -1.3039 Td
(stage)Tj
2.1996 0 Td
(drug,)Tj
2.3358 0 Td
(which)Tj
2.6532 0 Td
(is)Tj
0.8504 0 Td
(known)Tj
3.0047 0 Td
(to)Tj
1.0204 0 Td
(treat)Tj
2.0466 0 Td
(early-late)Tj
3.9061 0 Td
(\(transition\))Tj
4.7962 0 Td
(stage)Tj
2.2054 0 Td
(HAT[)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(],)Tj
3.6623 0 Td
(but)Tj
1.5534 0 Td
(cannot)Tj
2.982 0 Td
(treat)Tj
2.041 0 Td
(stage)Tj
-35.2571 -1.2982 Td
(2)Tj
0.6916 0 Td
(disease)Tj
3.0217 0 Td
(as)Tj
1.0148 0 Td
(it)Tj
0.7824 0 Td
(does)Tj
2.0409 0 Td
(not)Tj
1.5761 0 Td
(sufficiently)Tj
4.6091 0 Td
(penetrate)Tj
3.9628 0 Td
(the)Tj
1.4683 0 Td
(BBB[)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(])Tj
3.1124 0 Td
(and)Tj
1.7348 0 Td
(it)Tj
0.7824 0 Td
(causes)Tj
2.7496 0 Td
(peripheral)Tj
4.3199 0 Td
(side)Tj
1.8029 0 Td
(effects)Tj
-33.6697 -1.2983 Td
(\(e.g.)Tj
1.8992 0 Td
(hypoglycaemia)Tj
6.1908 0 Td
(\(incidence)Tj
4.4163 0 Td
(540%\))Tj
3.2598 0 Td
(and)Tj
1.7292 0 Td
(diabetes)Tj
3.4639 0 Td
(mellitus)Tj
3.4129 0 Td
(\(incidence:)Tj
4.6374 0 Td
(occasional)Tj
4.371 0 Td
(but)Tj
1.5534 0 Td
(irre-)Tj
-34.9339 -1.3039 Td
(versible\)[)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(])Tj
4.7678 0 Td
(which)Tj
2.6532 0 Td
(preclude)Tj
3.6794 0 Td
(increasing)Tj
4.3313 0 Td
(the)Tj
1.4683 0 Td
(dose)Tj
2.0409 0 Td
(to)Tj
1.0205 0 Td
(overcome)Tj
4.1499 0 Td
(this)Tj
1.6781 0 Td
(limitation.)Tj
4.3993 0 Td
(Research)Tj
3.8041 0 Td
(has)Tj
-33.9928 -1.2983 Td
(shown)Tj
2.8459 0 Td
(pentamidine)Tj
5.2951 0 Td
(has)Tj
1.542 0 Td
(a)Tj
0.6577 0 Td
(limited)Tj
3.067 0 Td
(ability)Tj
2.6929 0 Td
(to)Tj
1.0262 0 Td
(cross)Tj
2.245 0 Td
(the)Tj
1.4683 0 Td
(BBB)Tj
1.9616 0 Td
(and)Tj
1.7291 0 Td
(reach)Tj
2.3981 0 Td
(the)Tj
1.474 0 Td
(brain)Tj
2.3471 0 Td
(due)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(it)Tj
ET
Q
q
1 j
1 J
0.0001 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
Q
q
34.9795 742.734 216.567 12.3591 re
W* n
q
1 0 0 1 34.9795 742.734 cm
q
/I5 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 340.441 745.795 cm
BT
/F0 1 Tf
-0.005 Tc
1 TL
0 0 Td
(Pentamid)Tj
4.1527 0 Td
(ine)Tj
1.5237 0 Td
(reformulat)Tj
4.4221 0 Td
(ion)Tj
1.5236 0 Td
(to)Tj
1.0417 0 Td
(improve)Tj
3.7205 0 Td
(treatment)Tj
4.3796 0 Td
(of)Tj
1.0417 0 Td
(sleeping)Tj
3.8623 0 Td
(sickness)Tj
ET
Q
q
1 j
1 J
0.0001 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
163.559 34.9228 m
317.707 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
-0.005 Tc
1 TL
0 0 Td
(PLOS)Tj
2.8559 0 Td
(Neglected)Tj
4.6417 0 Td
(Tropical)Tj
3.7135 0 Td
(Disease)Tj
3.5433 0 Td
(s)Tj
0.7158 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8197 0 Td
(1/journal.pn)Tj
5.1237 0 Td
(td.00092)Tj
3.8197 0 Td
(76)Tj
0 g
2.0905 0 Td
(April)Tj
2.1827 0 Td
(15,)Tj
1.5804 0 Td
(2021)Tj
25.1647 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(31)Tj
ET
Q
q
0.83 0.64 0.02 0 k
1 j
1 J
0.0001 w
155.565 663.647 m
176.655 663.647 l
h
f*
36 652.649 m
182.948 652.649 l
h
f*
36 641.65 m
183.685 641.65 l
h
f*
36 630.652 m
169.228 630.652 l
h
f*
52.6677 586.658 m
112.479 586.658 l
h
f*
117.524 553.663 m
182.268 553.663 l
h
f*
102.331 509.613 m
171.099 509.613 l
h
f*
0 g
7.9999 0 0 7.9999 36 708.718 cm
BT
/F10 1 Tf
-0.025 Tc
1 TL
0 0 Td
(Funding:)Tj
/F11 1 Tf
3.5716 0 Td
(This)Tj
1.7788 0 Td
(research)Tj
3.4158 0 Td
(was)Tj
1.7008 0 Td
(funded)Tj
2.7921 0 Td
(by)Tj
1.1197 0 Td
(a)Tj
0.6378 0 Td
(Medical)Tj
-15.0166 -1.3748 Td
(Research)Tj
3.6992 0 Td
(Council)Tj
2.9693 0 Td
(\(MRC\))Tj
2.7 0 Td
(development)Tj
4.7835 0 Td
(al)Tj
0.8363 0 Td
(pathway)Tj
-14.9883 -1.3748 Td
(funding)Tj
3.033 0 Td
(scheme)Tj
3.1324 0 Td
(\(DPFS\))Tj
2.8984 0 Td
(award)Tj
2.4803 0 Td
([MR/K015)Tj
3.8481 0 Td
(451/1])Tj
2.6788 0 Td
(to)Tj
-18.071 -1.3748 Td
(SAT)Tj
1.7433 0 Td
(\(PI\),)Tj
1.8425 0 Td
(CAD,)Tj
2.0835 0 Td
(CL,)Tj
1.4386 0 Td
(SJP,)Tj
1.9205 0 Td
(MC)Tj
1.4953 0 Td
(\(all)Tj
1.3322 0 Td
(at)Tj
0.9001 0 Td
(King's)Tj
2.5016 0 Td
(College)Tj
-15.2576 -1.3748 Td
(London\),)Tj
3.5929 0 Td
(VY)Tj
1.2685 0 Td
(and)Tj
1.5874 0 Td
(SLC)Tj
1.7433 0 Td
(\(both)Tj
2.204 0 Td
(at)Tj
0.9 0 Td
(LSHTM\))Tj
3.3378 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(https://)Tj
-14.6339 -1.3748 Td
(mrc.ukri.org)Tj
4.5779 0 Td
(/funding/brow)Tj
5.2229 0 Td
(se/biomed)Tj
3.8835 0 Td
(ical-catalyst-)Tj
-13.6843 -1.3748 Td
(dpfs/biom)Tj
3.7701 0 Td
(edical-catalys)Tj
4.989 0 Td
(t-developme)Tj
4.6134 0 Td
(ntal-pathway-)Tj
-13.3725 -1.3748 Td
(funding-sch)Tj
4.4362 0 Td
(eme-dpfs-subm)Tj
5.9599 0 Td
(ission-deadl)Tj
4.4646 0 Td
(ines/)Tj
0 g
-14.8607 -1.3749 Td
(accessed)Tj
3.6425 0 Td
(20.03.2020\))Tj
4.5426 0 Td
(.)Tj
0.4464 0 Td
(This)Tj
1.7788 0 Td
(research)Tj
3.4157 0 Td
(was)Tj
1.7008 0 Td
(also)Tj
-15.5268 -1.3748 Td
(supported)Tj
3.9897 0 Td
(by)Tj
1.1197 0 Td
(a)Tj
0.6378 0 Td
(MRC)Tj
2.0906 0 Td
(PhD)Tj
1.8071 0 Td
(students)Tj
3.189 0 Td
(hip)Tj
1.3606 0 Td
([MR/)Tj
-14.1945 -1.3748 Td
(K500811/1])Tj
4.6205 0 Td
(\(to)Tj
1.2543 0 Td
(GNS)Tj
1.9205 0 Td
(and)Tj
1.5945 0 Td
(supervise)Tj
3.5504 0 Td
(d)Tj
0.6945 0 Td
(by)Tj
1.1126 0 Td
(SAT)Tj
1.7433 0 Td
(and)Tj
-16.4906 -1.3748 Td
(CAD;)Tj
0.83 0.64 0.02 0 k
2.0834 0 Td
(https://mr)Tj
3.6709 0 Td
(c.ukri.org/)Tj
0 g
3.9969 0 Td
(accessed)Tj
3.6426 0 Td
(20.3.2020\).)Tj
-13.3938 -1.3748 Td
(The)Tj
1.5874 0 Td
(BBSRC)Tj
2.9126 0 Td
(Centre)Tj
2.6221 0 Td
(of)Tj
0.9496 0 Td
(Integrative)Tj
4.1173 0 Td
(Biomedicine)Tj
-12.189 -1.3748 Td
(provided)Tj
3.4582 0 Td
(funding)Tj
3.0331 0 Td
(for)Tj
1.2544 0 Td
(the)Tj
1.3748 0 Td
(haemoly)Tj
3.1536 0 Td
(sis)Tj
1.2614 0 Td
(assay)Tj
2.3244 0 Td
(\(SAT)Tj
-15.8599 -1.3748 Td
(and)Tj
1.5874 0 Td
(LAD\))Tj
2.1118 0 Td
([BB/E527098/1])Tj
6.1867 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(https://bbs)Tj
4.2874 0 Td
(rc.ukri.org/)Tj
0 g
-14.1733 -1.3749 Td
(accessed)Tj
3.6425 0 Td
(20.3.2020\))Tj
4.0677 0 Td
(.)Tj
0.4465 0 Td
(A)Tj
0.7441 0 Td
(multi-user)Tj
4.0181 0 Td
(equipment)Tj
-12.9189 -1.3748 Td
(grant)Tj
2.1543 0 Td
(from)Tj
2.0055 0 Td
(the)Tj
1.3678 0 Td
(Wellcome)Tj
3.9047 0 Td
(Trust)Tj
2.1544 0 Td
(provided)Tj
3.4583 0 Td
(a)Tj
0.6378 0 Td
(Perkin-)Tj
-15.6828 -1.3748 Td
(Elmer)Tj
2.3669 0 Td
(Tricarb)Tj
2.8205 0 Td
(2900TR)Tj
3.1748 0 Td
(liquid)Tj
2.2181 0 Td
(scintillati)Tj
3.2103 0 Td
(on)Tj
1.1693 0 Td
(counter)Tj
-14.9599 -1.3819 Td
([080268])Tj
3.6779 0 Td
(to)Tj
0.9426 0 Td
(SAT)Tj
1.7504 0 Td
(\(PI\))Tj
1.6086 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(https://wellc)Tj
4.7906 0 Td
(ome.ac.uk/)Tj
0 g
-12.7701 -1.3748 Td
(accessed)Tj
3.6425 0 Td
(20.3.2020\))Tj
4.0677 0 Td
(.)Tj
0.4465 0 Td
(The)Tj
1.5874 0 Td
(funders)Tj
3.0473 0 Td
(had)Tj
1.5874 0 Td
(no)Tj
1.1693 0 Td
(role)Tj
1.6158 0 Td
(in)Tj
-17.1639 -1.3748 Td
(study)Tj
2.2677 0 Td
(design,)Tj
2.8984 0 Td
(data)Tj
1.793 0 Td
(collection)Tj
3.7346 0 Td
(and)Tj
1.5874 0 Td
(analysis,)Tj
3.4158 0 Td
(decision)Tj
-15.6969 -1.3748 Td
(to)Tj
0.9496 0 Td
(publish,)Tj
3.1464 0 Td
(or)Tj
0.9993 0 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9425 0 Td
(the)Tj
1.3748 0 Td
(manuscript.)Tj
/F10 1 Tf
-11.8559 -2.1189 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F11 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3749 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
3.3874 0 Td
(exist.)Tj
ET
Q
endstream
endobj
42 0 obj
<>
endobj
44 0 obj
<>/ProcSet 15 0 R/XObject<>>>
endobj
45 0 obj
[48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R]
endobj
48 0 obj
<>/Border[0 0 0]>>
endobj
49 0 obj
<>/Border[0 0 0]>>
endobj
50 0 obj
<>/Border[0 0 0]>>
endobj
51 0 obj
<>/Border[0 0 0]>>
endobj
52 0 obj
<>/Border[0 0 0]>>
endobj
53 0 obj
<>/Border[0 0 0]>>
endobj
54 0 obj
<>/Border[0 0 0]>>
endobj
55 0 obj
<>/Border[0 0 0]>>
endobj
56 0 obj
<>/Border[0 0 0]>>
endobj
57 0 obj
<>/Border[0 0 0]>>
endobj
58 0 obj
<>/Border[0 0 0]>>
endobj
59 0 obj
<>/Border[0 0 0]>>
endobj
60 0 obj
<>/Border[0 0 0]>>
endobj
61 0 obj
<>/Border[0 0 0]>>
endobj
62 0 obj
<>/Border[0 0 0]>>
endobj
63 0 obj
<>/Border[0 0 0]>>
endobj
64 0 obj
<>/Border[0 0 0]>>
endobj
65 0 obj
<>/Border[0 0 0]>>
endobj
66 0 obj
<>/Border[0 0 0]>>
endobj
67 0 obj
<>/Border[0 0 0]>>
endobj
68 0 obj
<>/Border[0 0 0]>>
endobj
69 0 obj
<>/Border[0 0 0]>>
endobj
70 0 obj
<>/Border[0 0 0]>>
endobj
71 0 obj
<>/Border[0 0 0]>>
endobj
72 0 obj
<>/Border[0 0 0]>>
endobj
73 0 obj
<>/Border[0 0 0]>>
endobj
75 0 obj
<>
endobj
74 0 obj
<>/Border[0 0 0]>>
endobj
76 0 obj
<>
endobj
43 0 obj
<>stream
q
Q
q
12.0189 54.5953 583.087 707.414 re
W* n
q
1 0 0 1 12.0189 54.5953 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
0.83 0.64 0.02 0 k
436.479 580.706 m
441.241 580.706 l
h
f*
484.441 580.706 m
510.803 580.706 l
h
f*
421.455 502.696 m
450.595 502.696 l
h
f*
263.679 450.709 m
273.203 450.709 l
h
f*
478.885 424.687 m
488.409 424.687 l
h
f*
531.269 411.704 m
540.737 411.704 l
h
f*
545.216 411.704 m
554.74 411.704 l
h
f*
464.995 372.699 m
474.52 372.699 l
h
f*
529.398 333.694 m
538.923 333.694 l
h
f*
203.414 320.712 m
232.554 320.712 l
h
f*
271.162 281.707 m
280.687 281.707 l
h
f*
422.816 281.707 m
432.34 281.707 l
h
f*
436.819 281.707 m
446.287 281.707 l
h
f*
450.765 281.707 m
460.29 281.707 l
h
f*
461.48 255.685 m
470.948 255.685 l
h
f*
475.427 255.685 m
484.951 255.685 l
h
f*
490.11 255.685 m
499.635 255.685 l
h
f*
359.15 242.702 m
368.674 242.702 l
h
f*
249.335 229.72 m
258.86 229.72 l
h
f*
254.835 203.698 m
264.359 203.698 l
h
f*
268.781 203.698 m
278.306 203.698 l
h
f*
519.874 177.732 m
529.342 177.732 l
h
f*
300.132 138.728 m
309.657 138.728 l
h
f*
540.68 112.706 m
560.239 112.706 l
h
f*
0 g
1 j
1 J
0.0001 w
10 0 0 10 200.012 594.765 cm
BT
/F9 1 Tf
-0.004 Tc
1 TL
0 0 Td
(physicochemical)Tj
6.8427 0 Td
(characteristics)Tj
5.9017 0 Td
(and)Tj
1.7348 0 Td
(its)Tj
1.1452 0 Td
(removal)Tj
3.4753 0 Td
(by)Tj
1.1848 0 Td
(the)Tj
1.4684 0 Td
(efflux)Tj
2.4548 0 Td
(transporters)Tj
5.0853 0 Td
(P-glycoprotein)Tj
-29.293 -1.2982 Td
(\(Pgp\))Tj
2.4377 0 Td
(and)Tj
1.7348 0 Td
(multi-drug)Tj
4.6205 0 Td
(resistance)Tj
4.1329 0 Td
(associated)Tj
4.2576 0 Td
(protein)Tj
3.1521 0 Td
(\(MRP\))Tj
2.9707 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(])Tj
1.3776 0 Td
(\(Fig)Tj
1.8198 0 Td
(A)Tj
0.9014 0 Td
(in)Tj
0.83 0.64 0.02 0 k
1.0375 0 Td
(S1)Tj
1.1735 0 Td
(File)Tj
0 g
(\).)Tj
2.2507 0 Td
(Furthermore,)Tj
-31.8668 -1.2983 Td
(transporters)Tj
5.0796 0 Td
(are)Tj
1.4513 0 Td
(considered)Tj
4.5978 0 Td
(essential)Tj
3.583 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(mode)Tj
2.5001 0 Td
(of)Tj
1.0148 0 Td
(action)Tj
2.6986 0 Td
(of)Tj
1.0148 0 Td
(pentamidine)Tj
5.2951 0 Td
(against)Tj
-29.7409 -1.3039 Td
(trypanosomes.)Tj
1.1962 -1.2983 Td
(Poloxamers,)Tj
5.142 0 Td
(with)Tj
1.9956 0 Td
(commercial)Tj
4.9549 0 Td
(trademark)Tj
4.3993 0 Td
(Pluronics)Tj
4.0309 0 Td
(\(BASF\))Tj
3.1691 0 Td
(or)Tj
1.0941 0 Td
(Synperonics)Tj
5.1194 0 Td
(\(CRODA\),)Tj
4.5807 0 Td
(are)Tj
-35.6822 -1.2982 Td
(triblock)Tj
3.3278 0 Td
(copolymers)Tj
4.8359 0 Td
(made)Tj
2.4151 0 Td
(of)Tj
1.0091 0 Td
(two)Tj
1.6951 0 Td
(poly\(ethylene)Tj
5.6239 0 Td
(oxide\))Tj
2.7383 0 Td
(\(PEO\))Tj
2.7666 0 Td
(blocks)Tj
2.7496 0 Td
(interspaced)Tj
4.8075 0 Td
(by)Tj
1.1678 0 Td
(a)Tj
0.6463 0 Td
(poly\(pro-)Tj
-33.783 -1.2983 Td
(pylene)Tj
2.8346 0 Td
(oxide\))Tj
2.7496 0 Td
(\(PPO\))Tj
2.7666 0 Td
(block)Tj
2.3981 0 Td
(and)Tj
1.7291 0 Td
(follow)Tj
2.6985 0 Td
(the)Tj
1.4684 0 Td
(general)Tj
3.1351 0 Td
(basic)Tj
2.211 0 Td
(formula:)Tj
3.6397 0 Td
(PEO)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.4999 0 0 6.6659 475.087 515.112 cm
BT
/F9 1 Tf
-0.0053 Tc
1 TL
0 0 Td
(x)Tj
ET
Q
q
1 j
1 J
0.0001 w
10 0 0 10 478.545 516.813 cm
BT
/F9 1 Tf
-0.004 Tc
1 TL
0 0 Td
(-PPO)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.4999 0 0 6.6659 500.712 515.112 cm
BT
/F9 1 Tf
-0.0053 Tc
1 TL
0 0 Td
(y)Tj
ET
Q
q
1 j
1 J
0.0001 w
10 0 0 10 504.113 516.813 cm
BT
/F9 1 Tf
-0.004 Tc
1 TL
0 0 Td
(-PEO)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.4999 0 0 6.6659 526.337 515.112 cm
BT
/F9 1 Tf
-0.0053 Tc
1 TL
0 0 Td
(x)Tj
ET
Q
q
1 j
1 J
0.0001 w
10 0 0 10 529.852 516.813 cm
BT
/F9 1 Tf
-0.004 Tc
1 TL
0 0 Td
(,)Tj
0.4422 0 Td
(where)Tj
2.6532 0 Td
(x)Tj
-36.0791 -1.3039 Td
(and)Tj
1.7291 0 Td
(y)Tj
0.6747 0 Td
(are)Tj
1.4513 0 Td
(the)Tj
1.4684 0 Td
(size)Tj
1.6837 0 Td
(of)Tj
1.0148 0 Td
(PEO)Tj
2.092 0 Td
(and)Tj
1.7348 0 Td
(PPO)Tj
2.0806 0 Td
(blocks,)Tj
2.9877 0 Td
(respectively)Tj
4.8869 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Table)Tj
2.7779 0 Td
(1)Tj
0 g
(\).)Tj
1.2643 0 Td
(In)Tj
1.1055 0 Td
(an)Tj
1.2075 0 Td
(aqueous)Tj
3.5036 0 Td
(environment)Tj
-31.6628 -1.2982 Td
(and)Tj
1.7291 0 Td
(above)Tj
2.5455 0 Td
(the)Tj
1.4684 0 Td
(critical)Tj
2.9537 0 Td
(micelle)Tj
3.067 0 Td
(concentration)Tj
5.8224 0 Td
(\(CMC\),)Tj
3.3448 0 Td
(the)Tj
1.4683 0 Td
(copolymers)Tj
4.8529 0 Td
(self-assemble)Tj
5.4652 0 Td
(into)Tj
-32.7173 -1.2983 Td
(micelles,)Tj
3.6567 0 Td
(with)Tj
1.9956 0 Td
(the)Tj
1.4683 0 Td
(PEO)Tj
2.0976 0 Td
(chains)Tj
2.778 0 Td
(forming)Tj
3.4866 0 Td
(a)Tj
0.6576 0 Td
(hydrophilic)Tj
4.8585 0 Td
(shell)Tj
2.024 0 Td
(around)Tj
3.1351 0 Td
(a)Tj
0.6519 0 Td
(PPO)Tj
2.0863 0 Td
(hydrophobic)Tj
5.3574 0 Td
(core,)Tj
-34.2536 -1.3039 Td
(within)Tj
2.812 0 Td
(which)Tj
2.6475 0 Td
(lipophilic)Tj
4.0082 0 Td
(drugs)Tj
2.4718 0 Td
(can)Tj
1.627 0 Td
(be)Tj
1.1509 0 Td
(solubilised,)Tj
4.6885 0 Td
(drug-free)Tj
3.9685 0 Td
(fraction)Tj
3.3562 0 Td
(decreased)Tj
4.1385 0 Td
(and)Tj
1.7291 0 Td
(circulation)Tj
-32.5982 -1.2983 Td
(time)Tj
2.0296 0 Td
(increased)Tj
3.9968 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
2.0807 0 Td
(A)Tj
0.9014 0 Td
(variety)Tj
2.9253 0 Td
(of)Tj
1.0148 0 Td
(Pluronic)Tj
3.668 0 Td
(block)Tj
2.3981 0 Td
(copolymers)Tj
4.8529 0 Td
(differing)Tj
3.668 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(lengths)Tj
3.0897 0 Td
(of)Tj
1.0147 0 Td
(the)Tj
1.4684 0 Td
(EO)Tj
-35.6142 -1.2982 Td
(and)Tj
1.7291 0 Td
(PO)Tj
1.5251 0 Td
(blocks)Tj
2.7609 0 Td
(are)Tj
1.4513 0 Td
(available)Tj
3.6624 0 Td
(for)Tj
1.3889 0 Td
(formulation)Tj
5.0343 0 Td
(with)Tj
1.9956 0 Td
(pharmaceutical)Tj
6.3723 0 Td
(drugs.)Tj
2.6929 0 Td
(Importantly)Tj
5.0568 0 Td
(the)Tj
1.4684 0 Td
(size)Tj
-35.138 -1.304 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(hydrophobic)Tj
5.3574 0 Td
(block)Tj
2.3981 0 Td
(affects)Tj
2.7382 0 Td
(micellization)Tj
5.3802 0 Td
(and)Tj
1.7291 0 Td
(drug)Tj
2.1146 0 Td
(solubilisation[)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
7.4211 0 Td
(Furthermore,)Tj
5.6124 0 Td
(com-)Tj
-35.2343 -1.2982 Td
(bining)Tj
2.8233 0 Td
(different)Tj
3.6567 0 Td
(Pluronics)Tj
4.0308 0 Td
(can)Tj
1.6271 0 Td
(enhance)Tj
3.549 0 Td
(drug/micelle)Tj
5.2894 0 Td
(interactions)Tj
4.9662 0 Td
(and)Tj
1.7348 0 Td
(drug)Tj
2.109 0 Td
(loading[)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
4.7337 0 Td
(13)Tj
0 g
(].)Tj
-34.52 -1.2983 Td
(The)Tj
1.7802 0 Td
(PEO)Tj
2.0976 0 Td
(shell)Tj
2.0239 0 Td
(serves)Tj
2.6135 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(stabilizing)Tj
4.2973 0 Td
(layer)Tj
2.1486 0 Td
(between)Tj
3.532 0 Td
(the)Tj
1.4683 0 Td
(hydrophobic)Tj
5.3575 0 Td
(core)Tj
1.9445 0 Td
(and)Tj
1.7292 0 Td
(the)Tj
1.4683 0 Td
(external)Tj
-32.1277 -1.3039 Td
(medium,)Tj
3.8268 0 Td
(and)Tj
1.7348 0 Td
(prevents)Tj
3.6169 0 Td
(aggregation,)Tj
5.1251 0 Td
(plasma)Tj
3.033 0 Td
(protein)Tj
3.1521 0 Td
(adsorption)Tj
4.5581 0 Td
(and)Tj
1.7291 0 Td
(opsonization)Tj
5.3971 0 Td
(and)Tj
1.7291 0 Td
(therefore)Tj
-33.9021 -1.2983 Td
(recognition)Tj
4.8472 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4684 0 Td
(macrophages)Tj
5.5048 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(reticuloendothelia)Tj
7.2736 0 Td
(l)Tj
0.4649 0 Td
(system)Tj
2.9367 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
2.0749 0 Td
(Pluronic)Tj
3.6737 0 Td
(copolymers)Tj
-31.9066 -1.2982 Td
(are)Tj
1.4457 0 Td
(also)Tj
1.7688 0 Td
(endowed)Tj
3.8608 0 Td
(with)Tj
2.0012 0 Td
(low)Tj
1.6554 0 Td
(cytotoxicity)Tj
4.8869 0 Td
(and)Tj
1.7291 0 Td
(weak)Tj
2.2564 0 Td
(immunogenicity)Tj
6.8598 0 Td
(in)Tj
1.0375 0 Td
(topical)Tj
2.9083 0 Td
(and)Tj
1.7348 0 Td
(systemic)Tj
-32.1447 -1.2983 Td
(administration.)Tj
6.3949 0 Td
(Even)Tj
2.2167 0 Td
(though)Tj
3.0728 0 Td
(PEOPPOPEO)Tj
6.8711 0 Td
(materials)Tj
3.8721 0 Td
(are)Tj
1.4513 0 Td
(non-degradable,)Tj
6.7578 0 Td
(molecules)Tj
4.2008 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
-36.8331 -1.3039 Td
(molecular)Tj
4.2179 0 Td
(weight)Tj
2.8857 0 Td
(\(MW\))Tj
/F14 1 Tf
0 Tc
2.7609 0 Td
(<)Tj
/F9 1 Tf
-0.004 Tc
(7)Tj
1.4457 0 Td
(kDa)Tj
1.8822 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1508 0 Td
(filtered)Tj
3.0671 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4683 0 Td
(kidney)Tj
2.9424 0 Td
(and)Tj
1.7291 0 Td
(cleared)Tj
3.0671 0 Td
(in)Tj
1.0374 0 Td
(urine[)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(])Tj
-30.4609 -1.2983 Td
(\()Tj
0.83 0.64 0.02 0 k
(Table)Tj
2.778 0 Td
(1)Tj
0 g
(\).)Tj
1.2642 0 Td
(In)Tj
1.1055 0 Td
(addition,)Tj
3.8268 0 Td
(Pluronics)Tj
4.0308 0 Td
(are)Tj
1.4457 0 Td
(recognised)Tj
4.541 0 Td
(pharmaceutical)Tj
6.3666 0 Td
(excipients)Tj
4.2179 0 Td
(listed)Tj
2.3414 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4682 0 Td
(US)Tj
1.4344 0 Td
(and)Tj
-35.858 -1.2982 Td
(British)Tj
2.8913 0 Td
(Pharmacopoeia)Tj
6.446 0 Td
(so)Tj
1.0885 0 Td
(have)Tj
2.0579 0 Td
(an)Tj
1.2019 0 Td
(established)Tj
4.5978 0 Td
(safety)Tj
2.4774 0 Td
(profile.)Tj
-19.5646 -1.304 Td
(Thus)Tj
2.2507 0 Td
(Pluronics)Tj
4.0309 0 Td
(have)Tj
2.0579 0 Td
(attracted)Tj
3.7304 0 Td
(a)Tj
0.6519 0 Td
(great)Tj
2.2167 0 Td
(deal)Tj
1.8482 0 Td
(of)Tj
1.0148 0 Td
(attention)Tj
3.8438 0 Td
(in)Tj
1.0374 0 Td
(pharmaceutical)Tj
6.3666 0 Td
(applications)Tj
5.0399 0 Td
(as)Tj
-35.2854 -1.2982 Td
(drug)Tj
2.109 0 Td
(solubilisers)Tj
4.6658 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(])Tj
1.8538 0 Td
(or)Tj
1.0999 0 Td
(controlled)Tj
4.3199 0 Td
(drug-release)Tj
5.1421 0 Td
(agents)Tj
2.7495 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7405 0 Td
(16)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.3946 0 Td
(17)Tj
0 g
(].)Tj
1.7348 0 Td
(Notably,)Tj
3.6284 0 Td
(Pluronic)Tj
3.6735 0 Td
(P85,)Tj
-34.1118 -1.2983 Td
(P105,)Tj
2.4321 0 Td
(F68)Tj
1.6951 0 Td
(and)Tj
1.7348 0 Td
(L61)Tj
1.7065 0 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.126 0 Td
(shown)Tj
2.846 0 Td
(to)Tj
1.0261 0 Td
(inhibit)Tj
2.9026 0 Td
(efflux)Tj
2.4605 0 Td
(transporters)Tj
5.0797 0 Td
(\(including)Tj
4.3823 0 Td
(P-gp)Tj
2.1146 0 Td
(and)Tj
1.729 0 Td
(MRP1-)Tj
-34.2932 -1.3039 Td
(2\))Tj
1.0318 0 Td
(and)Tj
1.7348 0 Td
(have)Tj
2.058 0 Td
(been)Tj
2.1203 0 Td
(shown)Tj
2.8516 0 Td
(to)Tj
1.0261 0 Td
(enhance)Tj
3.549 0 Td
(drug)Tj
2.1089 0 Td
(passage)Tj
3.2202 0 Td
(across)Tj
2.6759 0 Td
(the)Tj
1.4683 0 Td
(BBB)Tj
1.9616 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(18)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(29)Tj
0 g
(].)Tj
3.2031 0 Td
(They)Tj
2.2393 0 Td
(have)Tj
2.0579 0 Td
(all)Tj
-35.0416 -1.2983 Td
(been)Tj
2.1203 0 Td
(approved)Tj
3.9742 0 Td
(as)Tj
1.0148 0 Td
(cosmetic)Tj
3.7417 0 Td
(ingredients)Tj
4.7225 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(])Tj
1.8538 0 Td
(with)Tj
1.9956 0 Td
(F68)Tj
1.7008 0 Td
(having)Tj
2.914 0 Td
(been)Tj
2.1259 0 Td
(utilized)Tj
3.1918 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(blood)Tj
2.5114 0 Td
(substitute)Tj
-33.5336 -1.2982 Td
(component[)Tj
0.83 0.64 0.02 0 k
(30)Tj
0 g
(].)Tj
6.6671 0 Td
(Transporter-targeti)Tj
7.7272 0 Td
(ng)Tj
1.2302 0 Td
(Pluronics)Tj
4.0308 0 Td
(\(L61)Tj
2.0523 0 Td
(and)Tj
1.7291 0 Td
(F127\))Tj
2.5172 0 Td
(have)Tj
2.0579 0 Td
(successfully)Tj
4.8642 0 Td
(completed)Tj
-32.876 -1.2983 Td
(a)Tj
0.652 0 Td
(phase)Tj
2.4831 0 Td
(2)Tj
0.6973 0 Td
(clinical)Tj
3.0728 0 Td
(trial)Tj
1.8425 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.4683 0 Td
(intravenous)Tj
4.9606 0 Td
(treatment)Tj
4.1386 0 Td
(of)Tj
1.0148 0 Td
(adenocarcinoma)Tj
6.8881 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(upper)Tj
2.5795 0 Td
(gastroin-)Tj
-33.664 -1.3039 Td
(testinal)Tj
3.0954 0 Td
(tract)Tj
2.0466 0 Td
([)Tj
0.83 0.64 0.02 0 k
(31)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(32)Tj
0 g
(].)Tj
1.7405 0 Td
(Interestingly,)Tj
5.4878 0 Td
(F127-based)Tj
4.7792 0 Td
(amphotericin)Tj
5.6239 0 Td
(B-containing)Tj
5.4595 0 Td
(micelles)Tj
3.4298 0 Td
(have)Tj
2.0636 0 Td
(been)Tj
-35.4611 -1.2983 Td
(shown)Tj
2.846 0 Td
(to)Tj
1.0261 0 Td
(be)Tj
1.1509 0 Td
(highly)Tj
2.7099 0 Td
(effective)Tj
3.5093 0 Td
(in)Tj
1.0374 0 Td
(treating)Tj
/F13 1 Tf
3.3222 0 Td
(\r )Tj
4.8075 0 Td
( \r)Tj
/F9 1 Tf
(-infected)Tj
8.7931 0 Td
(BALB/c)Tj
3.3562 0 Td
(mice)Tj
2.1542 0 Td
(with)Tj
-34.7128 -1.2983 Td
(results)Tj
2.8063 0 Td
(indicating)Tj
4.269 0 Td
(that)Tj
1.7801 0 Td
(the)Tj
1.4683 0 Td
(empty)Tj
2.7326 0 Td
(micelles)Tj
3.4299 0 Td
(also)Tj
1.7688 0 Td
(exhibited)Tj
3.9288 0 Td
(antileishmanial)Tj
6.3439 0 Td
(activity)Tj
3.1181 0 Td
([)Tj
0.83 0.64 0.02 0 k
(33)Tj
0 g
(].)Tj
2.0749 0 Td
(Together)Tj
-33.7207 -1.3039 Td
(these)Tj
2.2507 0 Td
(studies)Tj
2.9877 0 Td
(demonstrate)Tj
5.2327 0 Td
(that)Tj
1.7802 0 Td
(Pluronics)Tj
4.0308 0 Td
(have)Tj
2.058 0 Td
(potential)Tj
3.7643 0 Td
(beyond)Tj
3.1862 0 Td
(the)Tj
1.4683 0 Td
(traditional)Tj
4.422 0 Td
(role)Tj
1.7688 0 Td
(of)Tj
1.0147 0 Td
(simple)Tj
-33.9644 -1.2982 Td
(micellar)Tj
3.4526 0 Td
(vessels)Tj
2.846 0 Td
(for)Tj
1.3889 0 Td
(drug)Tj
2.109 0 Td
(encapsulation)Tj
5.76 0 Td
(and)Tj
1.7291 0 Td
(longer)Tj
2.7836 0 Td
(circulation,)Tj
4.7565 0 Td
(but)Tj
1.5534 0 Td
(are)Tj
1.4513 0 Td
(also)Tj
1.7688 0 Td
(active)Tj
2.5172 0 Td
(agents)Tj
2.7551 0 Td
(with)Tj
-34.8715 -1.2983 Td
(key)Tj
1.5931 0 Td
(biological)Tj
4.0875 0 Td
(functions)Tj
3.9912 0 Td
([)Tj
0.83 0.64 0.02 0 k
(34)Tj
0 g
(].)Tj
-8.4756 -1.3039 Td
(In)Tj
1.1112 0 Td
(this)Tj
1.6724 0 Td
(Medical)Tj
3.4356 0 Td
(Research)Tj
3.8041 0 Td
(Council)Tj
3.4072 0 Td
(\(MRC\))Tj
3.0784 0 Td
(developmental)Tj
6.0888 0 Td
(pathway)Tj
3.5716 0 Td
(funding)Tj
3.3902 0 Td
(scheme)Tj
3.1974 0 Td
(\(DPFS\))Tj
-33.9531 -1.2983 Td
(study)Tj
2.3868 0 Td
(our)Tj
1.6271 0 Td
(multi-disciplinary)Tj
7.4153 0 Td
(team)Tj
2.194 0 Td
(developed)Tj
4.2747 0 Td
(a)Tj
0.6519 0 Td
(milestone)Tj
4.1159 0 Td
(driven)Tj
2.812 0 Td
(progression)Tj
4.9209 0 Td
(strategy)Tj
3.3277 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8199 0 Td
(1)Tj
0 g
(\))Tj
1.0318 0 Td
(in)Tj
-36.578 -1.2982 Td
(order)Tj
2.4208 0 Td
(to)Tj
1.0261 0 Td
(assess)Tj
2.5172 0 Td
(the)Tj
1.474 0 Td
(potential)Tj
3.7587 0 Td
(of)Tj
1.0148 0 Td
(pentamidine-Pluronic)Tj
9.0935 0 Td
(formulations)Tj
5.3971 0 Td
(to)Tj
1.0262 0 Td
(effectively)Tj
4.2122 0 Td
(treat)Tj
2.0465 0 Td
(stage)Tj
2.1997 0 Td
(2)Tj
-36.1868 -1.304 Td
(disease,)Tj
3.2428 0 Td
(reduce)Tj
2.914 0 Td
(the)Tj
1.474 0 Td
(major)Tj
2.6079 0 Td
(known)Tj
3.0047 0 Td
(side)Tj
1.7972 0 Td
(effect)Tj
2.364 0 Td
(of)Tj
1.0148 0 Td
(pentamidine)Tj
5.2951 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.474 0 Td
(pancreas)Tj
3.7304 0 Td
(and)Tj
1.7291 0 Td
(shorten)Tj
3.2597 0 Td
(the)Tj
ET
Q
q
0.45 0.36 0.35 0.01 k
1 j
1 J
0.0001 w
36 694.389 m
576 694.389 l
576 693.889 l
36 693.889 l
f*
102.544 693.889 m
102.544 681.389 l
102.044 681.389 l
102.044 693.889 l
f*
102.044 681.389 m
36 681.389 l
36 681.889 l
102.044 681.889 l
f*
164.778 693.889 m
164.778 681.389 l
164.278 681.389 l
164.278 693.889 l
f*
164.278 681.389 m
102.544 681.389 l
102.544 681.889 l
164.278 681.889 l
f*
213.221 693.889 m
213.221 681.389 l
212.721 681.389 l
212.721 693.889 l
f*
212.721 681.389 m
164.778 681.389 l
164.778 681.889 l
212.721 681.889 l
f*
318.69 693.889 m
318.69 681.389 l
318.19 681.389 l
318.19 693.889 l
f*
318.19 681.389 m
213.221 681.389 l
213.221 681.889 l
318.19 681.889 l
f*
424.324 693.889 m
424.324 681.389 l
423.824 681.389 l
423.824 693.889 l
f*
423.824 681.389 m
318.69 681.389 l
318.69 681.889 l
423.824 681.889 l
f*
473.183 693.889 m
473.183 681.389 l
472.683 681.389 l
472.683 693.889 l
f*
472.683 681.389 m
424.324 681.389 l
424.324 681.889 l
472.683 681.889 l
f*
575.999 681.389 m
473.183 681.389 l
473.183 681.889 l
575.999 681.889 l
f*
102.544 681.389 m
102.544 668.889 l
102.044 668.889 l
102.044 681.389 l
f*
102.044 668.889 m
36 668.889 l
36 669.389 l
102.044 669.389 l
f*
164.778 681.389 m
164.778 668.889 l
164.278 668.889 l
164.278 681.389 l
f*
164.278 668.889 m
102.544 668.889 l
102.544 669.389 l
164.278 669.389 l
f*
213.221 681.389 m
213.221 668.889 l
212.721 668.889 l
212.721 681.389 l
f*
212.721 668.889 m
164.778 668.889 l
164.778 669.389 l
212.721 669.389 l
f*
318.69 681.389 m
318.69 668.889 l
318.19 668.889 l
318.19 681.389 l
f*
318.19 668.889 m
213.221 668.889 l
213.221 669.389 l
318.19 669.389 l
f*
424.324 681.389 m
424.324 668.889 l
423.824 668.889 l
423.824 681.389 l
f*
423.824 668.889 m
318.69 668.889 l
318.69 669.389 l
423.824 669.389 l
f*
473.183 681.389 m
473.183 668.889 l
472.683 668.889 l
472.683 681.389 l
f*
472.683 668.889 m
424.324 668.889 l
424.324 669.389 l
472.683 669.389 l
f*
575.999 668.889 m
473.183 668.889 l
473.183 669.389 l
575.999 669.389 l
f*
102.544 668.889 m
102.544 656.389 l
102.044 656.389 l
102.044 668.889 l
f*
102.044 656.389 m
36 656.389 l
36 656.889 l
102.044 656.889 l
f*
164.778 668.889 m
164.778 656.389 l
164.278 656.389 l
164.278 668.889 l
f*
164.278 656.389 m
102.544 656.389 l
102.544 656.889 l
164.278 656.889 l
f*
213.221 668.889 m
213.221 656.389 l
212.721 656.389 l
212.721 668.889 l
f*
212.721 656.389 m
164.778 656.389 l
164.778 656.889 l
212.721 656.889 l
f*
318.69 668.889 m
318.69 656.389 l
318.19 656.389 l
318.19 668.889 l
f*
318.19 656.389 m
213.221 656.389 l
213.221 656.889 l
318.19 656.889 l
f*
424.324 668.889 m
424.324 656.389 l
423.824 656.389 l
423.824 668.889 l
f*
423.824 656.389 m
318.69 656.389 l
318.69 656.889 l
423.824 656.889 l
f*
473.183 668.889 m
473.183 656.389 l
472.683 656.389 l
472.683 668.889 l
f*
472.683 656.389 m
424.324 656.389 l
424.324 656.889 l
472.683 656.889 l
f*
575.999 656.389 m
473.183 656.389 l
473.183 656.889 l
575.999 656.889 l
f*
102.544 656.389 m
102.544 643.889 l
102.044 643.889 l
102.044 656.389 l
f*
102.044 643.889 m
36 643.889 l
36 644.39 l
102.044 644.39 l
f*
164.778 656.389 m
164.778 643.889 l
164.278 643.889 l
164.278 656.389 l
f*
164.278 643.889 m
102.544 643.889 l
102.544 644.39 l
164.278 644.39 l
f*
213.221 656.389 m
213.221 643.889 l
212.721 643.889 l
212.721 656.389 l
f*
212.721 643.889 m
164.778 643.889 l
164.778 644.39 l
212.721 644.39 l
f*
318.69 656.389 m
318.69 643.889 l
318.19 643.889 l
318.19 656.389 l
f*
318.19 643.889 m
213.221 643.889 l
213.221 644.39 l
318.19 644.39 l
f*
424.324 656.389 m
424.324 643.889 l
423.824 643.889 l
423.824 656.389 l
f*
423.824 643.889 m
318.69 643.889 l
318.69 644.39 l
423.824 644.39 l
f*
473.183 656.389 m
473.183 643.889 l
472.683 643.889 l
472.683 656.389 l
f*
472.683 643.889 m
424.324 643.889 l
424.324 644.39 l
472.683 644.39 l
f*
575.999 643.889 m
473.183 643.889 l
473.183 644.39 l
575.999 644.39 l
f*
102.544 643.889 m
102.544 631.39 l
102.044 631.39 l
102.044 643.889 l
f*
102.044 631.39 m
36 631.39 l
36 631.89 l
102.044 631.89 l
f*
164.778 643.889 m
164.778 631.39 l
164.278 631.39 l
164.278 643.889 l
f*
164.278 631.39 m
102.544 631.39 l
102.544 631.89 l
164.278 631.89 l
f*
213.221 643.889 m
213.221 631.39 l
212.721 631.39 l
212.721 643.889 l
f*
212.721 631.39 m
164.778 631.39 l
164.778 631.89 l
212.721 631.89 l
f*
318.69 643.889 m
318.69 631.39 l
318.19 631.39 l
318.19 643.889 l
f*
318.19 631.39 m
213.221 631.39 l
213.221 631.89 l
318.19 631.89 l
f*
424.324 643.889 m
424.324 631.39 l
423.824 631.39 l
423.824 643.889 l
f*
423.824 631.39 m
318.69 631.39 l
318.69 631.89 l
423.824 631.89 l
f*
473.183 643.889 m
473.183 631.39 l
472.683 631.39 l
472.683 643.889 l
f*
472.683 631.39 m
424.324 631.39 l
424.324 631.89 l
472.683 631.89 l
f*
575.999 631.39 m
473.183 631.39 l
473.183 631.89 l
575.999 631.89 l
f*
0.83 0.64 0.02 0 k
36 618.293 m
185.443 618.293 l
h
f*
0 g
7.9999 0 0 7.9999 36 708.718 cm
BT
/F15 1 Tf
-0.005 Tc
1 TL
0 0 Td
(Table)Tj
2.5512 0 Td
(1.)Tj
1.1763 0 Td
(Pluronics)Tj
4.1953 0 Td
(used)Tj
2.119 0 Td
(in)Tj
1.063 0 Td
(this)Tj
1.7716 0 Td
(Study,)Tj
2.8489 0 Td
(with)Tj
2.0622 0 Td
(their)Tj
2.2252 0 Td
(Name,)Tj
2.9268 0 Td
(Block)Tj
2.5583 0 Td
(Compositio)Tj
4.8827 0 Td
(n,)Tj
1.0205 0 Td
(Hydrophilic)Tj
5.0528 0 Td
(-Lipophilic)Tj
4.8047 0 Td
(Balance)Tj
3.4583 0 Td
(\(HLB\))Tj
2.8631 0 Td
(and)Tj
1.7858 0 Td
(General)Tj
3.4937 0 Td
(Formula.)Tj
/F9 1 Tf
4.2662 0 Td
(L,)Tj
0.978 0 Td
(F)Tj
0.7441 0 Td
(or)Tj
1.0913 0 Td
(P)Tj
0.7795 0 Td
(refers)Tj
2.4379 0 Td
(to)Tj
1.0204 0 Td
(Liquid,)Tj
-64.1768 -1.1905 Td
(Flake,)Tj
2.5582 0 Td
(or)Tj
1.0914 0 Td
(Paste)Tj
2.2819 0 Td
(Physical)Tj
3.4725 0 Td
(Forms,)Tj
3.0118 0 Td
(respectively.)Tj
/F15 1 Tf
0 Tc
-10.7505 -1.8496 Td
(Poloxamer)Tj
8.6954 0 Td
(Pluronic)Tj
7.8024 0 Td
(MW)Tj
6.0307 0 Td
(Number)Tj
3.7276 0 Td
(of)Tj
1.0843 0 Td
(EO)Tj
1.5803 0 Td
(blocks)Tj
6.789 0 Td
(Number)Tj
3.7347 0 Td
(of)Tj
1.0772 0 Td
(PO)Tj
1.6016 0 Td
(blocks)Tj
6.7961 0 Td
(HLB)Tj
8.6812 0 Td
(Formula)Tj
/F9 1 Tf
-56.0414 -1.5662 Td
(235)Tj
8.1922 0 Td
(P85)Tj
6.7252 0 Td
(4600)Tj
9.5032 0 Td
(52.27)Tj
13.1954 0 Td
(39.66)Tj
10.2474 0 Td
(16)Tj
5.5984 0 Td
(EO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 500.088 670.564 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(26.13)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 512.901 671.868 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(PO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 523.389 670.564 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(39.66)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 536.258 671.868 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(EO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 546.803 670.564 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(26.13)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 61.7952 659.395 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(335)Tj
7.9583 0 Td
(P105)Tj
6.9591 0 Td
(6500)Tj
9.5032 0 Td
(73.86)Tj
13.1954 0 Td
(56.03)Tj
10.2473 0 Td
(15)Tj
5.5985 0 Td
(EO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 500.088 658.035 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(36.93)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 512.901 659.395 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(PO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 523.389 658.035 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(56.03)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 536.258 659.395 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(EO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 546.803 658.035 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(36.93)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 61.7952 646.866 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(188)Tj
8.2063 0 Td
(F68)Tj
6.7111 0 Td
(8400)Tj
9.2623 0 Td
(152.73)Tj
13.4363 0 Td
(28.97)Tj
10.2473 0 Td
(29)Tj
5.5985 0 Td
(EO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 500.088 645.562 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(76.37)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 512.901 646.866 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(PO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 523.389 645.562 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(28.97)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 536.258 646.866 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(EO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 546.803 645.562 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(76.37)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 61.7952 634.394 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(181)Tj
8.2063 0 Td
(L61)Tj
6.7111 0 Td
(1950)Tj
9.7442 0 Td
(4.55)Tj
12.9544 0 Td
(31.03)Tj
10.4812 0 Td
(3)Tj
7.0583 0 Td
(EO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 513.638 633.033 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 516.472 634.394 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(PO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 526.961 633.033 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(30)Tj
ET
Q
q
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 532.687 634.394 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(EO)Tj
ET
Q
q
1 j
1 J
0.0001 w
5.9998 0 0 5.3325 543.231 633.033 cm
BT
/F9 1 Tf
1 TL
0 0 Td
(2)Tj
ET
Q
q
0.83 0.64 0.02 0 k
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 36 619.37 cm
BT
/F11 1 Tf
-0.025 Tc
1 TL
0 0 Td
(https://do)Tj
3.5575 0 Td
(i.org/10.1371/j)Tj
5.4425 0 Td
(ournal.pntd.)Tj
4.4646 0 Td
(0009276.t0)Tj
4.2662 0 Td
(01)Tj
ET
Q
q
1 j
1 J
0.0001 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
Q
q
34.9795 742.734 216.567 12.3591 re
W* n
q
1 0 0 1 34.9795 742.734 cm
q
/I5 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0.0001 w
7.9999 0 0 7.9999 340.441 745.795 cm
BT
/F0 1 Tf
-0.005 Tc
1 TL
0 0 Td
(Pentamid)Tj
4.1527 0 Td
(ine)Tj
1.5237 0 Td
(reformulat)Tj
4.4221 0 Td
(ion)Tj
1.5236 0 Td
(to)Tj
1.0417 0 Td
(improve)Tj
3.7205 0 Td
(treatment)Tj
4.3796 0 Td
(of)Tj
1.0417 0 Td
(sleeping)Tj
3.8623 0 Td
(sickness)Tj
ET
Q
q
1 j
1 J
0.0001 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
163.559 34.9228 m
317.707 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
-0.005 Tc
1 TL
0 0 Td
(PLOS)Tj
2.8559 0 Td
(Neglected)Tj
4.6417 0 Td
(Tropical)Tj
3.7135 0 Td
(Disease)Tj
3.5433 0 Td
(s)Tj
0.7158 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8197 0 Td
(1/journal.pn)Tj
5.1237 0 Td
(td.00092)Tj
3.8197 0 Td
(76)Tj
0 g
2.0905 0 Td
(April)Tj
2.1827 0 Td
(15,)Tj
1.5804 0 Td
(2021)Tj
25.1647 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(31)Tj
ET
Q
endstream
endobj
77 0 obj
<>
endobj
79 0 obj
<>/ProcSet 15 0 R/XObject<>>>
endobj
82 0 obj
<>stream
x`րEw,X@!=TR ^"z -Mo7^HBGDiҋ$5ގq=sݝgf_?OiiZ~kgee]~n߾o߾-[߿cΝ7nܴiڵk 4tǏ߽{Wʕ+)))Ɇ
\ׯwss
:sw|@m[[ZHH*7y@4hΝ;70s_bD4hu:ώ;ԪSUcOyFVTRv)G&&Ɯ\NNÇ&NҲ]kwhaEd;%y@^1ԩSǎcIIɓ'/^{%$~whS@NQy#'N(פ*#[ҖGR9w͛7U_R4A7c 0<{p4h